BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 17385003)

  • 1. Enhanced TGF-beta/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor.
    Okazaki Y; Yamasaki Y; Uchida HA; Okamoto K; Satoh M; Maruyama K; Maeshima Y; Sugiyama H; Sugaya T; Kashihara N; Makino H
    Clin Exp Nephrol; 2007 Mar; 11(1):77-87. PubMed ID: 17385003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
    Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
    Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway.
    Li Z; Hong Z; Peng Z; Zhao Y; Shao R
    Hum Cell; 2018 Jul; 31(3):199-209. PubMed ID: 29549584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction.
    Fukami K; Ueda S; Yamagishi S; Kato S; Inagaki Y; Takeuchi M; Motomiya Y; Bucala R; Iida S; Tamaki K; Imaizumi T; Cooper ME; Okuda S
    Kidney Int; 2004 Dec; 66(6):2137-47. PubMed ID: 15569303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of KCa3.1 ameliorates renal fibrosis through the TGF-β1/Smad pathway in diabetic mice.
    Huang C; Shen S; Ma Q; Chen J; Gill A; Pollock CA; Chen XM
    Diabetes; 2013 Aug; 62(8):2923-34. PubMed ID: 23656889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygous mice for TGF-betaIIR gene are resistant to the progression of streptozotocin-induced diabetic nephropathy.
    Kim HW; Kim BC; Song CY; Kim JH; Hong HK; Lee HS
    Kidney Int; 2004 Nov; 66(5):1859-65. PubMed ID: 15496156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells.
    Isono M; Chen S; Hong SW; Iglesias-de la Cruz MC; Ziyadeh FN
    Biochem Biophys Res Commun; 2002 Sep; 296(5):1356-65. PubMed ID: 12207925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperlipidemia induced by high fat diet ingestion activates TGF-beta/Smad signaling pathway in the kidney of diabetic rats].
    Chen ZX; Xie XY; Yu RC; Zhang J; Lei MX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 33(10):906-12. PubMed ID: 19001732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
    Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
    Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dencichine ameliorates kidney injury in induced type II diabetic nephropathy via the TGF-β/Smad signalling pathway.
    Jie L; Pengcheng Q; Qiaoyan H; Linlin B; Meng Z; Fang W; Min J; Li Y; Ya Z; Qian Y; Siwang W
    Eur J Pharmacol; 2017 Oct; 812():196-205. PubMed ID: 28633927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation.
    Carvajal G; Rodríguez-Vita J; Rodrigues-Díez R; Sánchez-López E; Rupérez M; Cartier C; Esteban V; Ortiz A; Egido J; Mezzano SA; Ruiz-Ortega M
    Kidney Int; 2008 Sep; 74(5):585-95. PubMed ID: 18509316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
    Wang D; Zhang G; Chen X; Wei T; Liu C; Chen C; Gong Y; Wei Q
    Int J Mol Med; 2018 May; 41(5):2784-2792. PubMed ID: 29484381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes.
    Huang C; Kim Y; Caramori ML; Fish AJ; Rich SS; Miller ME; Russell GB; Mauer M
    Diabetes; 2002 Dec; 51(12):3577-81. PubMed ID: 12453917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regulatory effect of compound Coptidis Rhizoma capsule on unbalanced expression of renal tissue TGF-β1/BMP-7 and Smad signaling pathway in rats with early diabetic nephropathy].
    Liu S; Chen XQ; Tang LQ; Yu N; Zhang XL; Du HF
    Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(5):938-45. PubMed ID: 26087560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silymarin nanoliposomes attenuate renal injury on diabetic nephropathy rats via co-suppressing TGF-β/Smad and JAK2/STAT3/SOCS1 pathway.
    Chen Y; Chen L; Yang T
    Life Sci; 2021 Apr; 271():119197. PubMed ID: 33577847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.
    Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH
    Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway.
    Wang M; Chen DQ; Wang MC; Chen H; Chen L; Liu D; Zhao H; Zhao YY
    Phytomedicine; 2017 Dec; 36():243-253. PubMed ID: 29157821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connective tissue growth factor antagonizes transforming growth factor-β1/Smad signalling in renal mesangial cells.
    O'Donovan HC; Hickey F; Brazil DP; Kavanagh DH; Oliver N; Martin F; Godson C; Crean J
    Biochem J; 2012 Jan; 441(1):499-510. PubMed ID: 21871016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smad2 Phosphorylation in Diabetic Kidney Tubule Epithelial Cells Is Associated with Modulation of Several Transforming Growth Factor-β Family Members.
    Høj Thomsen L; Fog-Tonnesen M; Nielsen Fink L; Norlin J; de Vinuesa AG; Krarup Hansen T; de Heer E; Ten Dijke P; Rosendahl A
    Nephron; 2017; 135(4):291-306. PubMed ID: 28064277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats.
    Chen KH; Hung CC; Hsu HH; Jing YH; Yang CW; Chen JK
    Chem Biol Interact; 2011 Mar; 190(1):45-53. PubMed ID: 21300041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.